aldoxorubicin

[email protected]
aldoxorubicin
Trade Name
Orphan Indication Glioblastoma
USA Market Approval USA
USA Designation Date 2014-09-24 00:00:00
Sponsor NantCell, Inc.;9920 Jefferson Boulevard;Culver City, California, 90232
Related Access Program
Center Trials & Treatment – Glioblastoma by Gene Expression Profile Center Trials & Treatment – Glioblastoma Multiforme Northwest Biotherapeutics – Glioblastoma Multiforme Northwest Biotherapeutics – Glioblastoma Celldex Therapeutics – Recurrent GBM